#12953 on the rich list of 14,644 insiders
Ross Muken
Chief Executive Officer at SOPHiA GENETICS SA. Based in Boston, Massachusetts.
$5.9M
in disclosed stock, −$696K (−10.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 12953rd of 14,644
- Companies held
- 1
- Largest holding
- SOPH, 100.0% of total
- Latest SEC filing
- Nov 6, 2026
What the $5.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| SOPHiA GENETICS SA SOPH Ordinary Shares | Directly | 680,391 | $6.68 | $4.5M | 77.3% | Form 4, Nov 6, 2026 |
| SOPHiA GENETICS SA SOPH Ordinary Shares | Through Family Trust | 200,000 | $6.68 | $1.3M | 22.7% | Form 3, Mar 18, 2026 |
Share counts are the amounts Ross Muken reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Bought | SOPH | 20,000 | $6.86 | $137K | View |
| Oct 5, 2026 | Sold | SOPH | 9,838 | $8.13 | $80K | View |
| Sep 21, 2026 | Sold | SOPH | 422 | $8.33 | $4K | View |
| Jul 6, 2026 | Sold | SOPH | 9,838 | $5.22 | $51K | View |
| Jun 22, 2026 | Sold | SOPH | 422 | $5.38 | $2K | View |
| May 19, 2026 | Sold | SOPH | 761 | $4.60 | $4K | View |
| Apr 20, 2026 | Sold | SOPH | 760 | $5.20 | $4K | View |
| Apr 14, 2026 | Sold | SOPH | 2,800 | $4.96 | $14K | View |
| Apr 13, 2026 | Sold | SOPH | 4,442 | $4.77 | $21K | View |
| Apr 10, 2026 | Sold | SOPH | 3,687 | $4.69 | $17K | View |
| Apr 9, 2026 | Sold | SOPH | 1,950 | $4.74 | $9K | View |
| Apr 8, 2026 | Sold | SOPH | 2,786 | $4.84 | $13K | View |
| Apr 7, 2026 | Sold | SOPH | 2,424 | $4.87 | $12K | View |
| Apr 6, 2026 | Sold | SOPH | 2,600 | $4.85 | $13K | View |
| Mar 19, 2026 | Sold | SOPH | 1,183 | $4.79 | $6K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12950 | Simon Stephen Edwards Chief Financial Officer, Bloom Energy. San Jose, CA | $5.9M |
| 12951 | Nick Pizzie Chief Financial Officer, Axsome Therapeutics. New York, NY | $5.9M |
| 12952 | Robert J. Andersen Former Chief Financial Officer, Adeia. San Jose, CA | $5.9M |
| 12953 | Ross Muken Chief Executive Officer, SOPHiA GENETICS SA. Boston, MA | $5.9M |
| 12954 | Nicholas Augustinos Director, DexCom. San Diego, CA | $5.9M |
| 12955 | James T. Thompson Director, Hawkins. Roseville, MN | $5.9M |
| 12956 | Scott A. Richardson CEO & President, Celanese. Irving, TX | $5.9M |
Other SOPHiA GENETICS SA insiders
All SOPH insiders- Jurgi Camblong$22.6MExecutive Chairman. #4729 overall
- George Cardoza$2.2MChief Financial Officer. #12518 overall
- Didier Hirsch$1.6MDirector. #12125 overall
Questions
How much stock does Ross Muken own?
Ross Muken holds $5,881,012 in listed stock based on SEC filings and current prices, mostly SOPHiA GENETICS SA (SOPH). That ranks 12953rd on the Stock Rich List.
Is this Ross Muken's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Ross Muken last buy or sell stock?
The most recent open-market trade on file is a purchase of 20,000 SOPH shares on Nov 6, 2026 at $6.86.